Across TCGA pan-cancer cohorts, OR5AW1P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR5AW1P data layer.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR5AW1P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated OR5AW1P expression acts as an unfavorable survival marker, although some lineages such as LIHC and UCS show a favorable association.
LIHC, READ, and KIRC are the cancer types where OR5AW1P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.